SCHEMBL17098718

SCHEMBL17098718

O=C(CN(Cc1ccc(C(F)(F)F)cc1)C(=O)c1cnn(C2CCC(C(=O)O)CC2)c1C(F)(F)F)c1c(Cl)cccc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.36
CCR5 P51681 1/20 0.36
OPRM1 P35372 2/20 0.34
OPRD1 P41143 2/20 0.34
MAPT P10636 1/20 0.34
PTGER4 P35408 1/20 0.33
RORC P51449 3/20 0.33
DDR1 Q08345 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
DDR2 Q16832 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
MAP3K20 Q9NYL2 1/20 0.33
MAP3K2 Q9Y2U5 1/20 0.33
CASR P41180 1/20 0.33
AGTR2 P50052 1/20 0.33
UBE2M P61081 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.33
S1PR5 Q9H228 2/20 0.32
FABP4 P15090 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17098716 1.00 NR3C1 (0.36) NR3C1CCR5OPRM1OPRD1MAPT
SCHEMBL17110623 0.94 TAS2R14 (0.35) NR3C1MAPTRORCUBE2MDCUN1D1
SCHEMBL17098875 0.92 CRHR1 (0.35) NR3C1CCR5MAPTPTGER4AGTR2
SCHEMBL17098876 0.92 CRHR1 (0.35) NR3C1CCR5MAPTPTGER4AGTR2
SCHEMBL17097881 0.90 RORC (0.33) NR3C1CCR5MAPTRORCDDR1
SCHEMBL17097883 0.90 RORC (0.33) NR3C1CCR5MAPTRORCDDR1
SCHEMBL17098774 0.90 RORC (0.34) NR3C1MAPTRORC
SCHEMBL17098772 0.90 RORC (0.34) NR3C1MAPTRORC
SCHEMBL17098618 0.89 CCR5 (0.38) NR3C1CCR5MAPTDDR1MAPK11
SCHEMBL17098615 0.89 CCR5 (0.38) NR3C1CCR5MAPTDDR1MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA NR3C1 66/4885CCR5 597/4885OPRM1 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.